Skip to main content
SpringerLink
Log in
Book cover

Urological Care for Patients with Progressive Neurological Conditions pp 75–83Cite as

Parkinson’s Disease and Multiple System Atrophy

  • Chapter
  • First Online:

  • 359 Accesses

Abstract

Parkinson’s disease (PD) and multiple system atrophy (MSA) are degenerative neurological diseases that have significant urological manifestations. Both diseases can be accompanied by erectile dysfunction, nocturia, urgency, urgency incontinence, and urinary frequency. These diseases are quite different in their presentation with urological symptoms occurring after motor symptoms in PD and before in MSA. MSA is also much more likely to have obstructive or retention symptoms. It is important that urologists are aware of these diseases since some patients may present to them before their neurological disease is identified and the management of their lower urinary tract symptoms is also different. This chapter describes the neuropathology and presentation of these diseases and the urological treatment both conservative and surgical.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Brucker BM, Kalra S. Parkinson’s disease and its effect on the lower urinary tract: evaluation of complications and treatment strategies. Urol Clin North Am [Internet]. Elsevier Inc; 2017;44(3):415–28. Available from: https://doi.org/10.1016/j.ucl.2017.04.008.

  2. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318:121–34.

    Google Scholar 

  3. Cheon SM, Ha MS, Park MJ, Kim JW. Nonmotor symptoms of Parkinson’s disease: prevalence and awareness of patients and families. Parkinsonism Relat Disord. 2008;14(4):286–90.

    Article  PubMed  Google Scholar 

  4. McDonald C, Winge K, Burn DJ. Lower urinary tract symptoms in Parkinson’s disease: prevalence, aetiology and management. Parkinsonism Relat Disord. 2017;35:8–16.

    Google Scholar 

  5. Shibley R, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord. 2008;23(10):1428–34.

    Article  Google Scholar 

  6. Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N. Falls in outpatients with Parkinson’s disease. J Neurol [Internet]. 2005;252(11):1310–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15895303%5Cn. http://link.springer.com/10.1007/s00415-005-0855-3.

    Article  CAS  Google Scholar 

  7. Sakakibara R, Hattori T, Uchiyama T, Kita K, Asahina M, Suzuki A, et al. Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation? J Neurol Neurosurg Psychiatry. 2000;68(1):65–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Bonnet AM, Pichon J, Vidailhet M, Gouider-Khouja N, Robain G, Perrigot M, et al. Urinary disturbances in striatonigral degeneration and Parkinson’s disease: clinical and urodynamic aspects. Mov Disord. 1997;12(4):509–13.

    Article  CAS  PubMed  Google Scholar 

  9. Gray R, Stern G, Malone-lee J. Lower urinary tract dysfunction in Parkinson’s disease: changes relate to age and not disease. Age Ageing. 1995;24(6):499–504.

    Article  CAS  PubMed  Google Scholar 

  10. Campos-Sousa RN, Quagliato E, Da Silva BB, De Carvalho RM, Ribeiro CS, De Carvalho DFM. Urinary symptoms in Parkinson’s disease: prevalence and associated factors. Arq Neuropsiquiatr. 2003;61(2 B):359–63.

    Article  PubMed  Google Scholar 

  11. Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Videourodynamic and sphincter motor unit potential analyses in Parkinson’s disease and multiple system atrophy. J Neurol Neurosurg Psychiatry. 2001;71(5):600–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kirchhof K, Apostolidis AN, Mathias CJ, Fowler CJ. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res. 2003;15(4):293–8.

    Article  CAS  PubMed  Google Scholar 

  13. Kim KJ, Jeong SJ, Kim JM. Neurogenic bladder in progressive supranuclear palsy: a comparison with Parkinson’s disease and multiple system atrophy. Neurourol Urodyn. 2018;37(5):1724–30.

    Article  PubMed  Google Scholar 

  14. Kim M, Jung JH, Park J, Son H, Jeong SJ, Oh SJ, et al. Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson’s disease. Park Relat Disord [Internet]. Elsevier; 2015;21(3):205–10. Available from: https://doi.org/10.1016/j.parkreldis.2014.12.003.

  15. Bloch F, Pichon B, Bonnet AM, Pichon J, Vidailhet M, Roze E, et al. Urodynamic analysis in multiple system atrophy: characterisation of detrusor-sphincter dyssynergia. J Neurol. 2010;257(12):1986–91.

    Article  PubMed  Google Scholar 

  16. Liu Z, Uchiyama T, Sakakibara R, Yamamoto T. Underactive and overactive bladders are related to motor function and quality of life in Parkinson’s disease. Int Urol Nephrol. 2015;47(5):751–7.

    Article  PubMed  Google Scholar 

  17. Sakushima K, Yamazaki S, Fukuma S, Hayashino Y, Yabe I, Fukuhara S, et al. Influence of urinary urgency and other urinary disturbances on falls in Parkinson’s disease. J Neurol Sci. 2016;360:153–7.

    Article  PubMed  Google Scholar 

  18. Zesiewicz TA, Evatt M, Vaughan CP, Jahan I, Singer C, Ordorica R, et al. Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson’s disease. Park Relat Disord [Internet]. Elsevier Ltd; 2015;21(5):514–20. Available from: https://doi.org/10.1016/j.parkreldis.2015.02.025.

  19. Peyronnet B, Vurture G, Palma JA, Malacarne DR, Feigin A, Sussman RD, et al. Mirabegron in patients with Parkinson disease and overactive bladder symptoms: a retrospective cohort. Parkinsonism Relat Disord [Internet]. Elsevier; 2018;(April):0–1. Available from: https://doi.org/10.1016/j.parkreldis.2018.07.005.

  20. Cameron AP. Medical management of neurogenic bladder with oral therapy. Transl Androl Urol. 2016;5(1):51–62.

    PubMed  PubMed Central  Google Scholar 

  21. Brusa L, Petta F, Pisani A, Moschella V, Iani C, Stanzione P, et al. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease. Neurology. 2007;68(18):1455–9.

    Article  CAS  PubMed  Google Scholar 

  22. Kabay S, Canbaz Kabay S, Cetiner M, Mestan E, Sevim M, Ayas S, et al. The clinical and urodynamic results of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson’s disease. Urology. 2016;87:76–81.

    Article  PubMed  Google Scholar 

  23. Vurture G, Peyronnet B, Feigin A, Biagioni MC, Gilbert R, Rosenblum N, et al. Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson’s disease. Neurourol Urodyn. 2018;37(8):2669–77.

    Article  CAS  PubMed  Google Scholar 

  24. Knupfer S, Schneider S, Averhoff M, Naumann C, Deuschl G, Junemann K, et al. Preserved micturition after intradetrusor on a botulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson’s disease [Internet]. BMC Urol. 2016;16(1):55. Available from: http://www.biomedcentral.com/bmcurol%5Cn. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emex&NEWS=N&AN=611977267

    Article  PubMed  PubMed Central  Google Scholar 

  25. Peters KM, Kandagatla P, Killinger KA, Wolfert C, Boura JA. Clinical outcomes of sacral neuromodulation in patients with neurologic conditions. Urology. 2013;81(4):738–43.

    Article  PubMed  Google Scholar 

  26. Witte LP, Odekerken VJJ, Boel JA, Schuurman PR, Gerbrandy-Schreuders LC, de Bie RMA. Does deep brain stimulation improve lower urinary tract symptoms in Parkinson’s disease? Neurourol Urodyn. 2018;37(1):354–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Michigan, Ann Arbor, MI, USA

    Anne P. Cameron

Authors
  1. Anne P. Cameron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne P. Cameron .

Editor information

Editors and Affiliations

  1. Division of Neurourology and Pelvic Reconstruction, Department of Urology, University of Michigan Medical School, Ann Arbor, MI, USA

    John T. Stoffel

  2. Division of Urology, Department of Surgery, Greenville Health System, Greenville, SC, USA

    Elizabeth V. Dray

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cameron, A.P. (2020). Parkinson’s Disease and Multiple System Atrophy. In: Stoffel, J.T., Dray, E.V. (eds) Urological Care for Patients with Progressive Neurological Conditions. Springer, Cham. https://doi.org/10.1007/978-3-030-23277-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-23277-1_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-23276-4

  • Online ISBN: 978-3-030-23277-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation